Oriola-KD Corporation revises recognised loss from the sale of Russian businesses

Oriola-KD Corporation Stock Exchange Release 2 February 2015 at 12:00 a.m.

Oriola-KD Corporation revises recognised loss from the sale of Russian businesses

Oriola-KD Corporation ("Oriola-KD" or the "Company") has previously stated in its stock exchange release on 8^th December 2014 that the Company has entered into an agreement to sell its Russian businesses to the Russian pharmacy chain CJSC "Apteki 36.6". The cash and debt free selling price was RUB 3,700 million, stated to be equivalent to approximately EUR 56 million. The price was paid in cash. Oriola-KD classified Russian businesses in accordance with IFRS 5 as a discontinued operation, and stated to recognise estimated loss of EUR 26 million.

The Company revises previously stated estimated loss due to a technical error on earlier calculation. The revision does not change Oriola-KD's prior estimate on the effect of the sale on the Oriola-KD Group's equity. The impairment loss resulting from the revaluing the assets at fair value, accumulated translation differences recognized through income statement, foreign exchange loss from conversion of the selling price and cost of disposal included within loss from discontinued operations totaled approximately EUR 147.7 million. Foreign exchange loss from conversion of the selling price was approximately EUR 4.8 million.

Oriola-KD will publish its financial statements release for 2014 on February 6, 2015 at about 8:30 a.m.

Oriola-KD Corporation

Tuomas Itkonen
CFO

For further information, please contact:

Tuomas Itkonen
CFO
Tel. +358 40 596 4004
email: tuomas.itkonen@oriola-kd.com

Eero Hautaniemi
President & CEO
Tel. +358 10 429 2109
email: eero.hautaniemi@oriola-kd.com

Distribution
NASDAQ OMX Helsinki Ltd.
Key media

Released by:
Oriola-KD Corporation
Corporate Communications
Orionintie 5
FI-02200 Espoo, Finland
www.oriola-kd.com